Literature DB >> 23659962

Enrichment map profiling of the cancer invasion front suggests regulation of colorectal cancer progression by the bone morphogenetic protein antagonist, gremlin-1.

George S Karagiannis1, Aaron Berk, Apostolos Dimitromanolakis, Eleftherios P Diamandis.   

Abstract

The cancer invasion front (CIF), a spatially-recognized area due to the frequent presence of peritumoral desmoplastic reaction, represents a cancer site where many hallmarks of cancer metastasis occur. It is now strongly suggested that the desmoplastic microenvironment holds crucial information for determining tumor development and progression. Despite extensive research on tumor-host cell interactions at CIFs, the exact paracrine molecular network that is hardwired into the proteome of the stromal and cancer subpopulations remains partially understood. Here, we interrogated the signaling pathways and the molecular functional signatures across the proteome of a desmoplastic coculture model system of colorectal cancer progression. We discovered a group of bone morphogenetic protein (BMP) antagonists that coordinates major biological programs in CIFs, including cell proliferation, invasion, migration and differentiation processes. Using a mathematical model of cancer cell progression, coupled to in vitro cell migration assays, we demonstrated that the prominent BMP antagonist gremlin-1 (GREM1) may trigger motility of cancer cell cohorts. Our data collectively demonstrate that the desmoplastic CIFs deploy a microenvironmental signature, based on BMP antagonism, in order to regulate the motogenic fates of cancer cell cohorts invading the adjacent stroma.
Copyright © 2013 Federation of European Biochemical Societies. All rights reserved.

Entities:  

Keywords:  ATCC; American type culture collection; BMP(I); Bone morphogenetic protein; CAF; CIF; COL12A1; CRC; Cancer-associated fibroblasts; Colorectal cancer; DMEM; DPD; Desmoplasia; Dulbecco's modified Eagle's medium; ECM; EMT; FBS; FST; FSTL3; GO; GREM1; Gremlin-1; HGF; HTRA3; IPA; IPKB; LOX; Migration; PDGF; TGF-β; VEGF(R2); alpha-smooth muscle actin; bone morphogenetic protein (inhibitor); cancer invasion front; cancer-associated fibroblast; collagen type XII; colorectal cancer; desmoplastic protein dataset; epithelial-to-mesenchymal transition; extracellular matrix; fetal bovine serum; follistatin; follistatin-like 3; gene ontology; gremlin-1; hepatocyte growth factor; high temperature requirement A3; ingenuity pathway analysis; ingenuity pathway knowledgebase; lysine-6-oxidase; platelet-derived growth factor; transforming growth factor-beta; uPA; urokinase-type plasminogen activator; vascular endothelial growth factor (receptor-2); α-SMA

Mesh:

Substances:

Year:  2013        PMID: 23659962      PMCID: PMC5528431          DOI: 10.1016/j.molonc.2013.04.002

Source DB:  PubMed          Journal:  Mol Oncol        ISSN: 1574-7891            Impact factor:   6.603


  68 in total

Review 1.  Tumor budding in colorectal carcinoma: time to take notice.

Authors:  Bojana Mitrovic; David F Schaeffer; Robert H Riddell; Richard Kirsch
Journal:  Mod Pathol       Date:  2012-07-13       Impact factor: 7.842

2.  Identification of epithelial to mesenchymal transition as a novel source of fibroblasts in intestinal fibrosis.

Authors:  Sarah N Flier; Harikrishna Tanjore; Efi G Kokkotou; Hikaru Sugimoto; Michael Zeisberg; Raghu Kalluri
Journal:  J Biol Chem       Date:  2010-04-02       Impact factor: 5.157

Review 3.  Cancer-associated fibroblasts drive the progression of metastasis through both paracrine and mechanical pressure on cancer tissue.

Authors:  George S Karagiannis; Theofilos Poutahidis; Susan E Erdman; Richard Kirsch; Robert H Riddell; Eleftherios P Diamandis
Journal:  Mol Cancer Res       Date:  2012-09-28       Impact factor: 5.852

Review 4.  Cancer secretomics reveal pathophysiological pathways in cancer molecular oncology.

Authors:  George S Karagiannis; Maria P Pavlou; Eleftherios P Diamandis
Journal:  Mol Oncol       Date:  2010-09-16       Impact factor: 6.603

5.  Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation.

Authors:  Julie B Sneddon; Hanson H Zhen; Kelli Montgomery; Matt van de Rijn; Aaron D Tward; Robert West; Hayes Gladstone; Howard Y Chang; Greg S Morganroth; Anthony E Oro; Patrick O Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-26       Impact factor: 11.205

Review 6.  Desmoplasia of pancreatic ductal adenocarcinoma.

Authors:  Stephen Pandol; Mouad Edderkaoui; Ilya Gukovsky; Aurelia Lugea; Anna Gukovskaya
Journal:  Clin Gastroenterol Hepatol       Date:  2009-11       Impact factor: 11.382

7.  Bone morphogenetic protein signalling is required for the anti-mitogenic effect of the proteasome inhibitor MG-132 on colon cancer cells.

Authors:  W K K Wu; J J Y Sung; Y C Wu; Z J Li; L Yu; C H Cho
Journal:  Br J Pharmacol       Date:  2008-04-14       Impact factor: 8.739

8.  A framework for mapping, visualisation and automatic model creation of signal-transduction networks.

Authors:  Carl-Fredrik Tiger; Falko Krause; Gunnar Cedersund; Robert Palmér; Edda Klipp; Stefan Hohmann; Hiroaki Kitano; Marcus Krantz
Journal:  Mol Syst Biol       Date:  2012-04-24       Impact factor: 11.429

9.  STRING 8--a global view on proteins and their functional interactions in 630 organisms.

Authors:  Lars J Jensen; Michael Kuhn; Manuel Stark; Samuel Chaffron; Chris Creevey; Jean Muller; Tobias Doerks; Philippe Julien; Alexander Roth; Milan Simonovic; Peer Bork; Christian von Mering
Journal:  Nucleic Acids Res       Date:  2008-10-21       Impact factor: 16.971

10.  The bone morphogenetic protein antagonist gremlin 1 is overexpressed in human cancers and interacts with YWHAH protein.

Authors:  Hong Namkoong; Seung Min Shin; Hyun Kee Kim; Seon-Ah Ha; Goang Won Cho; Soo Young Hur; Tae Eung Kim; Jin Woo Kim
Journal:  BMC Cancer       Date:  2006-03-18       Impact factor: 4.430

View more
  28 in total

1.  No evidence of Gremlin1-mediated activation of VEGFR2 signaling in endothelial cells.

Authors:  Louise R Dutton; Christina L O'Neill; Reinhold J Medina; Derek P Brazil
Journal:  J Biol Chem       Date:  2019-10-11       Impact factor: 5.157

2.  BMP pathway suppression is an early event in inflammation-driven colon neoplasmatogenesis of uPA-deficient mice.

Authors:  George S Karagiannis; Hara Afaloniati; Elisavet Karamanavi; Theofilos Poutahidis; Katerina Angelopoulou
Journal:  Tumour Biol       Date:  2015-09-10

3.  LncRNA PVT1 Facilitates Tumorigenesis and Progression of Glioma via Regulation of MiR-128-3p/GREM1 Axis and BMP Signaling Pathway.

Authors:  Chao Fu; Dongyuan Li; Xiaonan Zhang; Naijie Liu; Guonan Chi; Xingyi Jin
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

4.  Expression patterns of bone morphogenetic protein antagonists in colorectal cancer desmoplastic invasion fronts.

Authors:  George S Karagiannis; Ann Treacy; David Messenger; Andrea Grin; Richard Kirsch; Robert H Riddell; Eleftherios P Diamandis
Journal:  Mol Oncol       Date:  2014-04-19       Impact factor: 6.603

5.  Collective migration of cancer-associated fibroblasts is enhanced by overexpression of tight junction-associated proteins claudin-11 and occludin.

Authors:  George S Karagiannis; David F Schaeffer; Chan-Kyung J Cho; Natasha Musrap; Punit Saraon; Ihor Batruch; Andrea Grin; Bojana Mitrovic; Richard Kirsch; Robert H Riddell; Eleftherios P Diamandis
Journal:  Mol Oncol       Date:  2013-11-08       Impact factor: 6.603

6.  Bidirectional tumor/stroma crosstalk promotes metastasis in mesenchymal colorectal cancer.

Authors:  Sarah Ouahoud; Philip W Voorneveld; Lukas J A C Hawinkels; James C H Hardwick; Lennart R A van der Burg; Eveline S M de Jonge-Muller; Mark J A Schoonderwoerd; Madelon Paauwe; Thijs de Vos; Sophie de Wit; Gabi W van Pelt; Wilma E Mesker
Journal:  Oncogene       Date:  2020-01-23       Impact factor: 9.867

Review 7.  Bone Morphogenetic Protein Signaling Regulates Development and Activation of CD4(+) T Cells.

Authors:  Michal Kuczma; Piotr Kraj
Journal:  Vitam Horm       Date:  2015-06-27       Impact factor: 3.421

8.  The BMP pathway either enhances or inhibits the Wnt pathway depending on the SMAD4 and p53 status in CRC.

Authors:  P W Voorneveld; L L Kodach; R J Jacobs; C J M van Noesel; M P Peppelenbosch; K S Korkmaz; I Molendijk; E Dekker; H Morreau; G W van Pelt; R A E M Tollenaar; W Mesker; L J A C Hawinkels; M Paauwe; H W Verspaget; D T Geraets; D W Hommes; G J A Offerhaus; G R van den Brink; P Ten Dijke; J C H Hardwick
Journal:  Br J Cancer       Date:  2014-11-13       Impact factor: 7.640

9.  Functional annotation of colon cancer risk SNPs.

Authors:  Lijing Yao; Yu Gyoung Tak; Benjamin P Berman; Peggy J Farnham
Journal:  Nat Commun       Date:  2014-09-30       Impact factor: 14.919

10.  Circ_001209 aggravates diabetic retinal vascular dysfunction through regulating miR-15b-5p/COL12A1.

Authors:  Fang Wang; Meixia Zhang
Journal:  J Transl Med       Date:  2021-07-07       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.